Table 1.
PD Medications of Each Subject along with the Total LEDD
| Subject | PD Medications | LEDD, mg |
|---|---|---|
| 1 | CD/LD, amantadine, pramipexole, rasagiline | 675 |
| 2 | CD/LD ER, selegiline | 233 |
| 3 | Amantadine, pramipexole | 600 |
| 4 | CD/LD, selegiline, pramipexole ER | 1,000 |
| 5 | CD/LD, CD/LD CR, ropinirole | 460 |
| 6 | CD/LD, safinamide | 400 |
| 7 | CD/LD, ropinirole | 355 |
| 8 | CD/LD ER | 858 |
| 9 | CD/LD ER, ropinirole | 1,102 |
| 10 | CD/LD, rasagiline | 400 |
| 11 | CD/LD, rasagiline, amantadine ER | 970 |
| 12 | CD/LD, selegiline | 750 |
CD/LD = carbidopa/L‐dopa; CR = sustained release; ER = extended release; LEDD = L‐dopa equivalent daily dose.